Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Year: 2017
Type: review
Abstract: Cancer, the main cause of human deaths in the modern world is a group of diseases. Anticancer drug discovery is a challenge for scientists because of involvement of multiple survival pathways of cancer cells. An extensive study on the regulation of each step of these pathways may help find a potential cancer target. Up-regulated HIF-1 expression and altered metabolic pathways are two classical characteristics of cancer. Oxygen-dependent (through pVHL, PHDs, calcium-mediated) and independent (through growth factor signaling pathway, mdm2 pathway, HSP90) regulation of HIF-1α leads to angiogenesis, metastasis, and cell survival. The two subunits of HIF-1 regulates in the same fashion through different mechanisms. HIF-1α translation upregulates via mammalian target of rapamycin and mitogen-activated protein kinase signaling pathways, whereas HIF-1β through calmodulin kinase. Further, the stabilized interactions of these two subunits are important for proper functioning. Also, metabolic pathways crucial for the formation of building blocks (pentose phosphate pathway) and energy generation (glycolysis, TCA cycle and catabolism of glutamine) are altered in cancer cells to protect them from oxidative stress and to meet the reduced oxygen and nutrient supply. Up-regulated anaerobic metabolism occurs through enhanced expression of hexokinase, phosphofructokinase, triosephosphate isomerase, glucose 6-phosphate dehydrogenase and down-regulation of aerobic metabolism via pyruvate dehydrogenase kinase and lactate dehydrogenase which compensate energy requirements along with high glucose intake. Controlled expression of these two pathways through their common intermediate may serve as potent cancer target in future.
Source: Cell & Bioscience
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: hypoxia-inducible factor, HIF-1α, ARNT, cancer metabolism, glycolysis, pentose phosphate pathway, TCA cycle, glutamine catabolism, oxidative stress, mTOR signaling, MAPK signaling, calcium/calmodulin-dependent protein kinase, VHL, prolyl hydroxylase, HIF stabilization, angiogenesis, metastasis, cancer drug targets, anaerobic metabolism
Open Access status: gold
Estimated APC paid: $2,890
OpenAlex ID: W2768762463
